An overview of the impact of PACS as health informatics and technology e-health in healthcare management

2022 ◽  
pp. 101-128
Author(s):  
Reinaldo Padilha França ◽  
Ana Carolina Borges Monteiro ◽  
Rangel Arthur ◽  
Yuzo Iano
Keyword(s):  
Health Informatics ◽  
Healthcare Management ◽  
The Impact

scholarly journals Accreditation and Certification: Do They Improve Hospital Financial and Quality Performance?

Healthcare ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 887
Author(s):  
Matthew Brooks ◽  
Brad M. Beauvais ◽  
Clemens Scott Kruse ◽  
Lawrence Fulton ◽  
Michael Mileski ◽  
...  
Keyword(s):  
Higher Education ◽  
Positive Impact ◽  
Performance Outcomes ◽  
Healthcare Management ◽  
Academic Program ◽  
Future Research ◽  
Graduate Degree ◽  
Healthcare Administration ◽  
Professional Certification ◽  
The Impact

The relationship between healthcare organizational accreditation and their leaders’ professional certification in healthcare management is of specific interest to institutions of higher education and individuals in the healthcare management field. Since academic program accreditation is one piece of evidence of high-quality education, and since professional certification is an attestation to the knowledge, skills, and abilities of those who are certified, we expect alumni who graduated from accredited programs and obtained professional certification to have a positive impact on the organizations that they lead, compared with alumni who did not graduate from accredited programs and who did not obtain professional certification. The authors’ analysis examined the impact of hiring graduates from higher education programs that held external accreditation from the Commission on Accreditation of Healthcare Management Education (CAHME). Graduates’ affiliation with the American College of Healthcare Executives (ACHE) professional healthcare leadership organization was also assessed as an independent variable. Study outcomes focused on these graduates’ respective healthcare organization’s performance measures (cost, quality, and access) to assess the researchers’ inquiry into the perceived value of a CAHME-accredited graduate degree in healthcare administration and a professional ACHE affiliation. The results from this study found no effect of CAHME accreditation or ACHE affiliation on healthcare organization performance outcomes. The study findings support the need for future research surrounding healthcare administration professional graduate degree program characteristics and leader development affiliations, as perceived by various industry stakeholders.

FEATURES

2015 ◽  
Vol 19 (10) ◽  
pp. 17-35 ◽  
Keyword(s):  
Big Data ◽  
Disease Management ◽  
Clinical Research ◽  
Health Informatics ◽  
Healthcare Management ◽  
Spatial Awareness ◽  
Digital Tool ◽  
Future Health ◽  
Research Sector ◽  
The Future

Amplifying Spatial Awareness via GIS — Tech which brings Healthcare Management, Preventative & Predictive Measures under the same Cloud When it is not just about size, you gotta' be Smart, too! Chew on It! How Singapore-based health informatics company MHC Asia Group crunches big-data to uncover your company's health Digital tool when well-used, it is Passion Carving the Digital Route to Wellness Big Data, Bigger Disease Management and Current preparations to manage the Future Health of Singaporeans A Conversation with Mr Arun Puri Extreme Networks: Health Solutions Big Data in Clinical Research Sector

scholarly journals Where does the money go to? Cost analysis of gynecological patients with a benign condition

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0254124
Author(s):  
Kristiina Pynnä ◽  
Pirjo Räsänen ◽  
Risto P. Roine ◽  
Piia Vuorela ◽  
Harri Sintonen
Keyword(s):  
Clinical Care ◽  
Intrauterine Device ◽  
Productivity Loss ◽  
Hospital Costs ◽  
Healthcare Management ◽  
Hospital Treatment ◽  
Benign Condition ◽  
Hospital District ◽  
Hospital Size ◽  
The Impact

Objectives The impact of benign gynecological conditions on life of women and on costs for the society is high. The purpose of this study is to gain knowledge and understanding of costs of the treatment of these disorders in order to be able to improve the clinical care processes, gain insight into feasible savings opportunities and to allocate funds wisely. Methods The healthcare processes of 311 women attending university or community hospitals in the Helsinki and Uusimaa Hospital District between June 2012 and August 2013 due to a benign gynecological condition were followed up for two years and treatment costs analysed. Results Total direct hospital costs averaged 689€ at six months and 2194€ at two years. The most expensive treatment was that of uterine fibroids in the short term and that of endometriosis and fibroids later on. Costs did not depend on hospital size. Surgical operations caused nearly half of hospital costs. Productivity loss caused biggest expenses outside of the hospital. LNG-IUD (levonorgestrel-releasing intrauterine device) accounted for the largest pharmaceutical costs for patients. Hospital treatment was associated with a reduced need for outpatient services during follow-up. Conclusions A majority of direct hospital costs arise over time. This stresses the need for prolonged healthcare management. To control costs, the need for repetitive doctors’ appointments, monitoring tests, and ward treatments should be carefully evaluated. Procedures not needing an operation theatre (for example hysteroscopy for polypectomy), should be done ambulatorily.

scholarly journals Hospital at Home: An Evolving Model for Comprehensive Healthcare

2021 ◽  
Author(s):  
Henil Y. Patel ◽  
Daniel J. West
Keyword(s):  
Healthcare Services ◽  
The United States ◽  
Healthcare Management ◽  
Point Of View ◽  
Generation Model ◽  
Model Of Care ◽  
Treatment Protocols ◽  
Hospital At Home ◽  
The Impact ◽  
At Home

ABSTRACT Hospital at Home (HaH) is a sustainable, innovative, and next-generation model of healthcare. From the healthcare management point of view, this model provides cost benefits and quality improvement, and from the physicians' point of view, it helps in providing patient-centered medical care and keeps patients away from hospital admission and its complications. The HaH model was first introduced at John Hopkins in the United States in 1995, which showed very promising results in context to the length of stay, readmission rates, patient satisfaction, and hospital-acquired infections. The HaH model of care provides acute critical care to patients at home and reduces unnecessary hospitalization and related complications. The identified patients for this model of care are elderly patients with chronic conditions and multiple comorbidities. The emergence of technology in today's world and the impact of coronavirus disease 2019 (COVID-19) have increased the demand for the HaH model of care. Although there are many benefits and advantages, the HaH model of care has significant barriers and limitations, such as reimbursement for payment, physician and patient resistance, patient safety, and lack of quantifying research data to support the use of this model. Specific training for the physician, nursing, and other members of the HaH multidisciplinary team is necessary for HaH treatment protocols, along with patient and family caregiver education for those who elect the HaH model of care. HaH is the future of comprehensive healthcare services and helps in achieving the triple aim of access to healthcare, improved quality of care, and reduced cost for healthcare.

scholarly journals Beyond novelty effect: a mixed-methods exploration into the motivation for long-term activity tracker use

JAMIA Open ◽  
2018 ◽  
Vol 2 (1) ◽  
pp. 62-72 ◽  
Author(s):  
Grace Shin ◽  
Yuanyuan Feng ◽  
Mohammad Hossein Jarrahi ◽  
Nicci Gafinowitz
Keyword(s):  
Mixed Methods ◽  
Future Development ◽  
Health Informatics ◽  
Novelty Effect ◽  
Activity Tracker ◽  
Monitoring Technologies ◽  
Daily Physical Activities ◽  
Short Time ◽  
The Impact

Abstract Objectives Activity trackers hold the promise to support people in managing their health through quantified measurements about their daily physical activities. Monitoring personal health with quantified activity tracker-generated data provides patients with an opportunity to self-manage their health. Many have been conducted within short-time frames; makes it difficult to discover the impact of the activity tracker’s novelty effect or the reasons for the device’s long-term use. This study explores the impact of novelty effect on activity tracker adoption and the motivation for sustained use beyond the novelty period. Materials and methods This study uses a mixed-methods approach that combines both quantitative activity tracker log analysis and qualitative one-on-one interviews to develop a deeper behavioral understanding of 23 Fitbit device users who used their trackers for at least 2 months (range of use = 69–1073 days). Results Log data from users’ Fitbit devices revealed 2 stages: the novelty period and the long-term use period. The novelty period for Fitbit users in this study was approximately 3 months, during which they might have discontinued using their devices. Discussion The qualitative interview data identified various factors that users to continuously use the Fitbit devices in different stages. The discussion of these results provides design implications to guide future development of activity tracking technology. Conclusion This study reveals important dynamics emerging over long-term activity tracker use, contributes new knowledge to consumer health informatics and human-computer interaction, and offers design implications to guide future development of similar health-monitoring technologies that better account for long-term use in support of patient care and health self-management.

Impact of Privacy Issues on Successful Implementation of Personalized Medicare System

2019 ◽  
Vol 10 (3) ◽  
pp. 96-115
Author(s):  
Sandip Bisui ◽  
Subhas C. Misra
Keyword(s):  
Large Scale ◽  
Healthcare Management ◽  
Genomic Variation ◽  
Successful Implementation ◽  
Related Factors ◽  
Privacy Concerns ◽  
Novel Approach ◽  
Impact Of Technology ◽  
The Impact ◽  
Privacy Issues

Personalized medicare systems is an emerging field of research, which bears the potential to significantly reduce healthcare expenditures and treatment errors and thereby to revolutionize the entire treatment procedure. In this novel approach, genomic variation in different individuals is duly taken into consideration. However, there exist several serious issues (e.g. privacy concerns) that provide hindrance to large-scale adoption of this medicare system. The main objective of this study has been to identify the privacy issues and to evaluate their impact on successful implementation of this novel medical treatment. The methodology used is empirical and is based on a survey-based post facto procedure. The data collected from the survey are analyzed by using the method of structural modelling analysis. This is an original study in the realm of healthcare management, which reveals that the technology related factors and privacy concerns have considerable impact on the successful implementation of personalized medicare system on a large scale. But the privacy concerns have no significant moderating effect on the impact of technology related factors, so far, the success of implementation of personalized medicine is concerned.

Strategy in a Fishbowl An Invitation to Determine the Shape of IMIA in 2015

2006 ◽  
Vol 45 (03) ◽  
pp. 235-239 ◽  
Keyword(s):  
San Francisco ◽  
Health Informatics ◽  
Task Force ◽  
Early Stage ◽  
Strategic Plan ◽  
Concentric Circle ◽  
Central Core ◽  
General Assembly ◽  
Conference Calls ◽  
The Impact

Summary Objectives: The International Medical Informatics Association (IMIA) today is an inclusive organization that represents the medical and health informatics world through its multiple member countries as well as affiliate, corporate and academic institutions, plus working groups and regions. The IMIA leadership deemed this is an excellent time to create a strategic alignment of IMIA’s goals and in turn to create a framework of the IMIA agenda for the future. Methods: The process began in early 2004, with a survey distributed to all IMIA members seeking members‘ views. The initial views were presented to the IMIA Board and General Assembly at Medinfo 2004 in San Francisco, USA. A Strategic Planning Task Force was established to take forward the development of a Strategic Plan. Through a combination of e-mail exchanges, face-to-face planning-discussion sessions in Geneva, Switzerland, and Washington DC, USA, and use of mediated conference calls, the IMIA Strategic Plan was evolved. Results: The framework model (also known as the IMIA rainbow umbrella) seeks to represent, in visual and descriptive terms, the numerous possibilities for connections and integration. Knowledge is the central core of IMIA. All of our strategies, interactions and efforts, emanate from this knowledge core. Using a concentric circle model, the next circle (from the central core) represents science. This is followed by the application layer circle, then the impact layer/circle and finally the outermost circle represents the people layer. Another dimensionality of the IMIA Strategic Plan is the need to represent various key sectors. There are six sectors superimposed on the five concentric circle layers of IMIA’s integration and connection to others. These sectors represent: health (our vision), research and science, behavioral responsibility, education, relationships and reach. Conclusion: We are still at a relatively early stage of planning. The Strategic Framework and Plan will be discussed by the IMIA Board and the IMIA General Assembly meeting (November 2006).

scholarly journals The Impact of Diagnostic Code Misclassification on Optimizing the Experimental Design of Genetic Association Studies

2017 ◽  
Vol 2017 ◽  
pp. 1-5
Author(s):  
Steven J. Schrodi
Keyword(s):  
Genetic Association ◽  
Health Informatics ◽  
Association Studies ◽  
Genetic Association Studies ◽  
Experimental Designs ◽  
Diagnostic Code ◽  
Diagnostic Codes ◽  
Phenotype Classification ◽  
Misclassification Rates ◽  
The Impact

Diagnostic codes within electronic health record systems can vary widely in accuracy. It has been noted that the number of instances of a particular diagnostic code monotonically increases with the accuracy of disease phenotype classification. As a growing number of health system databases become linked with genomic data, it is critically important to understand the effect of this misclassification on the power of genetic association studies. Here, I investigate the impact of this diagnostic code misclassification on the power of genetic association studies with the aim to better inform experimental designs using health informatics data. The trade-off between (i) reduced misclassification rates from utilizing additional instances of a diagnostic code per individual and (ii) the resulting smaller sample size is explored, and general rules are presented to improve experimental designs.

scholarly journals Does health informatics have a replication crisis?

2018 ◽  
Vol 25 (8) ◽  
pp. 963-968 ◽  
Author(s):  
Enrico Coiera ◽  
Elske Ammenwerth ◽  
Andrew Georgiou ◽  
Farah Magrabi
Keyword(s):  
Health Informatics ◽  
Context Effects ◽  
Evidence Based ◽  
Medical Sciences ◽  
Replication Studies ◽  
Research Fields ◽  
Replication Crisis ◽  
The Cost ◽  
The Impact

Abstract Objective Many research fields, including psychology and basic medical sciences, struggle with poor reproducibility of reported studies. Biomedical and health informatics is unlikely to be immune to these challenges. This paper explores replication in informatics and the unique challenges the discipline faces. Methods Narrative review of recent literature on research replication challenges. Results While there is growing interest in re-analysis of existing data, experimental replication studies appear uncommon in informatics. Context effects are a particular challenge as they make ensuring replication fidelity difficult, and the same intervention will never quite reproduce the same result in different settings. Replication studies take many forms, trading-off testing validity of past findings against testing generalizability. Exact and partial replication designs emphasize testing validity while quasi and conceptual studies test generalizability of an underlying model or hypothesis with different methods or in a different setting. Conclusions The cost of poor replication is a weakening in the quality of published research and the evidence-based foundation of health informatics. The benefits of replication include increased rigor in research, and the development of evaluation methods that distinguish the impact of context and the nonreproducibility of research. Taking replication seriously is essential if biomedical and health informatics is to be an evidence-based discipline.

scholarly journals The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol (Preprint)

2020 ◽  
Author(s):  
Madison Milne-Ives ◽  
Ching Lam ◽  
Michelle van Velthoven ◽  
Edward Meinert
Keyword(s):  
United Kingdom ◽  
Supply Chain ◽  
Scoping Review ◽  
Grey Literature ◽  
Healthcare Management ◽  
Risk Of Bias ◽  
Pharmaceutical Supply Chain ◽  
The United Kingdom ◽  
The Uk ◽  
The Impact

BACKGROUND The continuing uncertainty around Brexit has caused concern in the pharmaceutical industry and among health care professionals and patients. The exact consequences of Brexit on the pharmaceutical supply chain in the United Kingdom will depend on whether a deal is reached and what it entails, but it is likely to be affected by the withdrawal of the United Kingdom from the European Union. Regulatory issues and delays in supply have the potential to negatively affect the ability of UK residents to receive an adequate and timely supply of necessary medicines. OBJECTIVE The purpose of this protocol is to provide an overview and critical analysis of current perspectives on the effect of Brexit on the UK pharmaceutical supply chain. METHODS The PRISMA-ScR (Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews) guidelines will be used to structure this protocol. A systematic search of MEDLINE, EMBASE, PsycINFO, Healthcare Management Information Consortium (HMIC), Cochrane, Web of Science, Business Source Complete, EconLit, and Economist Intelligence Unit will be conducted, as well as a Google and Nexis.UK search for grey literature such as reports, opinion pieces, and press releases. Two reviewers will independently screen the titles and abstracts of identified references and select studies according to the eligibility criteria. Any discrepancies will then be discussed and resolved. One reviewer will extract data from the included studies into a standardized form, which will be validated by a second reviewer. Risk of bias will be assessed using the Cochrane Collaboration Risk of Bias tool for any randomized controlled trials; quality will be assessed using the relevant Critical Appraisal Skills Programme (CASP) checklists; and grey literature will be assessed using the Authority, Accuracy, Coverage, Objectivity, Date, Significance (AACODS) checklist. Outcomes include the agreement between sources on the potential, likelihood, and severity of the consequences of Brexit on the UK pharmaceutical supply chain. RESULTS Results will be included in the scoping review, which will be published in 2020. CONCLUSIONS This scoping review will summarize the currently expected consequences of Brexit on the UK pharmaceutical supply chain. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/17684

Sign in / Sign up

Export Citation Format

Share Document